Navigation Links
Signalling pathways meeting targeting the HER/EGFR family: Focus on breast, lung and colorectal cancers
Date:2/25/2013

The ESMO symposium "Signalling Pathways Targeting the HER/EGFR family in breast, lung and colorectal cancers" is a unique event which will mark the start of a series of events that ESMO will specifically dedicate to issues around the widely debated topic of personalised cancer medicine.

Academic clinical researchers and industry researchers alike will be guided by an extraordinary panel of experts through the challenges and the novelties that the dissection of biomarkers are continuously bringing to the oncology field.

200 attendees are expected from throughout Europe and the rest of the world.

Highlights on:

  • Lively biomarkers: opportunities for liquid biopsy

  • Pitfalls and challenges with tumour tissue specimens

  • Tumour-host interaction: focus on immune response and microenvironment

  • EGFR/HER family targeted therapy in breast, colorectal and lung cancer

  • Adjuvant and neoadjuvant strategies in HER-2/neu breast disease

  • Predictive biomarkers of EGFR inhibition in colorectal cancer: what is there beyond KRAS?

  • Building on EGFR inhibition in lung cancer: Synthetic lethality strategies


'/>"/>

Contact: Press Office
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1

Related biology news :

1. Fragile X and Down syndromes share signalling pathway for intellectual disability
2. Thomas Jefferson University researchers discover new pathways that drive metastatic prostate cancer
3. Long-distance solute transport in trees improved by intercellular pathways in living woody tissues
4. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
5. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
6. Insects scientists and children meeting in Las Cruces, New Mexico
7. Meeting: Project aims to predict yield potential to help global food security
8. Press registration open for ASM Biodefense and Emerging Diseases Research Meeting
9. Media invited: Biophysical Society Annual Meeting
10. ACMG 2013 Clinical Genetics Meeting -- Complimentary press registration is now open
11. SSR 2013 Annual Meeting: Call for abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... , ... March 27, 2017 , ... PMG Research ... Collaborations (CTC) conference presented by The Conference Forum in Boston on April 3-4, ... collaborate to drive improved clinical trial outcomes and bring them closer to the patient. ...
(Date:3/24/2017)... Ga. , March 24, 2017 MiMedx ... biopharmaceutical company utilizing human placental tissue allografts and patent-protected ... for multiple sectors of healthcare, announced today  that it ... New York , NY.  Parker H. "Pete" ... Chief Financial Officer, Christopher M. Cashman , EVP ...
(Date:3/24/2017)... VILLAGE, Calif. , March 24, 2017   ... dermatology and aesthetics company, today announced that Richard ... Officer, effective March 24.   Peterson, who brings ... succeed John Smither , who is retiring at ... Sienna in an advisory capacity. Peterson joins Sienna from ...
(Date:3/23/2017)... 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), ... for solid tumor cancers, today announced that yesterday ... announced last Friday, March 17, 2017. ... securities totaling 28,843,692 shares, comprised of 18,843,692 common ... of Class C Warrants pre-funded at the closing ...
Breaking Biology Technology: